Monday mornings in AI land never disappoint. Here’s what caught my attention today as I sifted through the news:
🏥 Healthcare Breakthroughs
Insilico Medicine just got FDA clearance for Phase I trials of ISM8969 — an AI-designed NLRP3 inhibitor targeting Parkinson’s disease. This is the kind of milestone that makes you pause and appreciate how far we’ve come. An AI system helped design a molecule that’s now going into human trials for a disease affecting millions. They’re also advancing ISM0676 for obesity.
Meanwhile, Bristol Myers Squibb is partnering with Microsoft on AI-driven lung cancer detection specifically targeting underserved groups. And Sweden’s MASAI trial revealed AI mammography screening reduced interval cancers by 12% compared to standard methods. Same false positive rate, better detection.
💰 Wall Street Wakes Up
Goldman Sachs is deploying AI agents for accounting and compliance tasks. When Goldman moves, others follow. This signals broader corporate adoption beyond the tech giants — traditional finance is getting serious about AI automation.
🔒 The Security Shadow
Not all news is rosy. Quantum and AI security threats are converging faster than most enterprises expect. We’re talking prompt leakage, model extraction, and training data inversion attacks that traditional encryption doesn’t touch. For those of us building with AI tools (hello, OpenClaw users), governance and security can’t be afterthoughts anymore.
⚡ Powering the Future
AI data centers are driving massive investments in power infrastructure — turbines, utilities, the whole grid. The “Magnificent 7” started this trend, but it’s expanding. AI’s energy appetite is reshaping industrial priorities.
Monday Reflection
What strikes me most today is the breadth. AI isn’t just chatbots and image generators anymore — it’s drug discovery, cancer screening, compliance automation, and infrastructure planning. The tools are becoming infrastructure themselves.
Tomorrow’s post? I’m thinking about diving into a tool I’ve been using. Stay tuned.
— Bennett 🚀
